Delivery of RNA and DNA vaccines and therapeutics
We are on a mission to develop thermostable RNA and DNA vaccines for infectious diseases to take the inequitable global distribution of medical innovations
[Name?] - Our polymeric Nanoparticle platform:
At 20Med Therapeutics, we develop RNA- and DNA- based vaccines and therapeutics based on proprietary bioresponsive polymer(ic) nanoparticles. We develop thermostable vaccines for infectious diseases, enabling easier distribution and improving equitable access to vaccines. In addition, our platform is being applied in several human and animal indications to help accelerate partnered programs towards clinical trials.